Kyntra Bio (KYNB) Short-term Investments (2014 - 2026)

Kyntra Bio has reported Short-term Investments for 12 years, with the latest figure at $10.0 million in Q4 2025.

• Quarterly Short-term Investments changed N/A year-over-year to $10.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.0 million (changed N/A YoY) and the FY2025 annual result came in at $10.0 million, changed N/A from the prior year.
• Short-term Investments fell to $10.0 million in Q4 2025 per KYNB's latest filing, from $22.4 million in the prior quarter.
• Over five years, Short-term Investments peaked at $270.4 million in Q2 2022 and troughed at $4.5 million in Q2 2025.
• A 5-year average of $133.5 million and a median of $153.9 million in 2021 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2021 and 2023: Short-term Investments soared 2772.88% in 2021, then slumped 98.03% in 2023.
• Over 5 years, Short-term Investments stood at $234.0 million in 2021, then grew by 13.82% to $266.3 million in 2022, then tumbled by 54.23% to $121.9 million in 2023, then plunged by 93.88% to $7.5 million in 2024, then surged by 33.83% to $10.0 million in 2025.
• According to Business Quant data, Short-term Investments over the past three periods registered $10.0 million, $22.4 million, and $4.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.